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Tumor protrusion in hepatocellular carcinoma (HCC) is one of the risk signs of tumor rupture.  Despite 
curative tumor treatments,  HCC recurrences sometimes occur with rapidly growing humped or rup-
tured HCC in small sized tumors.  The aim of this study was to clarify the characteristics of humped 
HCC clinically and radiologically associated with tumor progression,  liver damage,  and treatment.  
The subjects were 179 consecutive HCC patients who underwent angiographic examination.  Dynamic 
studies,  using helical computed tomography and magnetic resonance imaging were assessed,  and the 
HCC area were measured.  The tumor-node-metastasis (TNM) stage diﬀered signiﬁcantly between the 
humped and non-humped HCC groups.  Humped HCC was more frequently observed in the right lobe 
(29.3ｵ of right-lobe HCCs) than in the left (10.1ｵ; p＝0.003).  Analysis of recurrent HCC revealed that 
patients with multiple treatments of ｧ4 sessions had more humped HCC (33.8ｵ) than those with 1-3 
sessions (16.7ｵ; p＝0.042).  Multivariate regression analysis revealed that tumor invasion in the portal 
vein,  rather than large tumor size,  was signiﬁcantly associated with tumor protrusion.  HCC recur-
rence with humped HCC occurs often in patients with multiple treatments.  Tumor factors of the TNM 
classiﬁcation,  especially tumor invasion in the portal vein,  might be associated with the mechanisms of 
tumor protrusion.
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epatocellular carcinoma (HCC) is the ﬁfth most 
common cancer worldwide,  and the incidence is 
likely to increase [1,  2].  The “hump sign,” compris-
ing tumor protrusion out of the liver margin,  repre-
sents one of the speciﬁc characteristics of HCC,  and 
is useful for diﬀerential diagnosis [3].  Furthermore,  
humped HCC is reported to have a high risk of spon-
taneous rupture that often results in fatal liver failure 
[4-7].  In the 1980s in Japan,  as in Taiwan [6],  
because periodic screenings for HCC were not well-
established for patients with the hepatitis B virus 
(HBV) or hepatitis C virus (HCV),  numerous HCC 
patients with large sized tumors suﬀered from sponta-
neous ruptures.  The patients with HBV or HCV often 
visited hospitals for abdominal pain from HCC rupture 
without any regular follow-ups.  Recently,  the number 
of spontaneous HCC rupture cases seems to be 
decreasing,  with only several ruptured cases annually 
at our hospital.  Regular follow-ups with periodic 
surveillance using helical computed tomography (CT),  
magnetic resonance imaging (MRI),  and ultrasound 
might detect HCC in earlier stages [8],  and with 
H
Acta Med.  Okayama,  2010
Vol.  64,  No.  5,  pp.  299ﾝ305
CopyrightⒸ 2010 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received January 12, 2010 ; accepted June 18, 2010.
＊Corresponding author. Phone : ＋81ﾝ897ﾝ37ﾝ7111; Fax : ＋81ﾝ897ﾝ37ﾝ7121
E-mail : takayuki_sanomura@ni.sbh.gr.jp (T. Sanomura)
these methods,  many patients could receive treatment 
before tumor rupture.
　 Several reports studied spontaneous HCC rupture 
in the natural course [6,  7],  and the comparison 
between ruptured and non-ruptured HCC revealed that 
tumors often become humped as they grow larger.  
Large tumor size may be one of the important factors 
for tumor protrusion.  However,  once the patients 
receive HCC treatments,  such as trans-catheter arte-
rial chemo-embolization (TACE) or ablation,  treat-
ments may modify the characteristics of HCC,  such as 
poor tumor diﬀerentiation or sarcomatous changes as 
previously reported [9,  10].  We occasionally experi-
enced recurrent HCCs that grew humped rapidly with 
tumor rupture in small sized tumors.  Understanding 
the precise characteristics of humped HCC is crucial 
for early detection to avoid tumor protrusion or rup-
ture.  Therefore,  we assessed humped HCC using 
angiography,  CT,  and MRI in order to clarify the 
characteristics of humped HCC associated with tumor 
progression,  liver damage,  treatment,  and other 
clinical parameters.
Materials and Methods
　 Study subjects. The subjects comprised 179 
HCC patients who underwent assessment using digital 
subtraction angiography (DSA) at our hospital for the 
diagnosis or treatment of HCC.  The patient back-
grounds are shown in Table 1.  The tumor-node-
metastasis (TNM) classiﬁcation,  the staging criteria 
of the Liver Cancer Study Group of Japan,  was used 
for staging tumor progression [11].  In terms of liver 
function,  we evaluated the patients using the Child-
Pugh stage [12].  The number of patients in Child-
Pugh stage C was much smaller than the numbers in 
stages A or B,  since some patients in Child-Pugh 
stage C did not receive DSA examinations due to poor 
liver condition.  The study was approved by the insti-
tutional ethics committee.
　 Assessment of humped HCC. Dynamic stud-
ies using helical CT and MRI within 1 month prior to 
DSA were assessed.  All HCCs with diameters ＞1cm 
based on CT or MRI images (axial view) were included 
for this analysis.  Humped HCC was deﬁned as a 
tumor with one-third or more of the area protruding 
from the liver surface,  and severely humped HCC as 
a protrusion of two-thirds or more of the area.  Image 
analysis was undertaken by measuring the HCC area 
using a TFS-7000 DICOM Viewer (Toshiba Medical 
Systems Corporation,  Tokyo,  Japan).  An example of 
an actual analysis is shown in Fig.  1.
　 Diagnosis and treatment of HCC. When 
HCCs were diagnosed with helical CT,  MRI,  or 
ultrasound,  the patients received DSA examinations 
to conﬁrm blood supplies to the HCC.  When blood 
supply to HCC through the hepatic arteries was 
scarce,  we also examined blood supply through extra-
hepatic vessels (ExHV),  as previously reported [13].  
All tumors were treated with TACE,  and additionally 
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Age (years) 71 (53-89)‡ 72 (55-89)‡ 71 (53-83)‡ 0.95
Gender (female/male) 37/142 16/35 21/107 0.026
Virus (HBV/HCV/none) 20/139/20 10/35/6 10/104/14 0.071
TNM stage (1/2/3/4) 20/27/91/41 1/1/28/21 19/26/63/20 ＜0.001
Child-Pugh (A/B/C) 108/62/9 27/23/1 81/39/8 0.12
Treatment (0/1-3/4-)† 44/63/72 13/13/25 31/50/47 0.19
AST (IU/L) 49 (16-250)‡ 51 (22-155)‡ 48 (16-250)‡ 0.44
ALT (IU/L) 41 (11-156)‡ 35 (11-156)‡ 44 (12-131)‡ 0.64
Platelet (104/µL) 11 (2-38)‡ 10 (2-38)‡ 11 (2-30)‡ 0.13
AFP (ng/mL) 24 (2-2×105)‡ 62 (2-2×105)‡ 21 (2-2×104)‡ 0.013
DCP (mAU/mL) 126 (10-6×103)‡ 217 (11-6×103)‡ 126 (10-6×103)‡ 0.006
TNM,  Tumor-node-metastasis stage according to the Liver Cancer Study Group of Japan; Treatment,  Treatment times over the 
lifetime; AST,  aspartate aminotransferase; ALT,  alanine aminotransferase; AFP,  Alpha fetoprotein; DCP,  des-gamma-carboxy prothrom-
bin; †: Sessions; ‡: Median (maximum-minimum).
with percutaneous ablation in case of tumor number 
ｦ3 and tumor size ｦ3cm in diameter.  Single tumors 
of ｦ3cm in diameter were resected if the patients 
were tolerant to the resection.  When the patients 
received several treatments such as TACE,  percuta-
neous ablation and resection within a 1-month interval,  
successive treatments were counted as 1 session of 
treatment for the analysis.
　 Statistical analysis. The Student t-test was 
used for comparing the patient backgrounds between 
the humped HCC and non-humped HCC group.  The 
Kruskal-Wallis test was utilized for the analysis of the 
associations between tumor size and location,  and the 
association of tumor protrusion with TNM stage and 
Child-Pugh stage.  The frequencies of humped HCC 
among the treatment groups were evaluated with the 
Kruskal-Wallis test.  The Fisher exact probability 
test,  x2 test,  and Student t-test were also used to 
compare the frequency of humped HCC between the 
two treatment groups.  The logistic regression analysis 
was utilized to determine factors that strongly aﬀect 
tumor protrusion.  P values of less than 0.05 were 
deﬁned as statistically signiﬁcant.
Results
　 Humped HCC was identiﬁed on 51 CT or MRI,  
and conﬁrmed with DSA examinations,  including 4 
cases with double humped HCCs.  As a result,  a total 
of 55 humped HCCs were studied.  Eighteen HCCs 
were severely humped.  Ten HCCs occupied over 2 
segments according to the Couinaud classiﬁcation.  
Table 1 shows the patient backgrounds.  In comparing 
the humped HCC and non-humped HCC group,  the 
high prevalence in the female patients,  advanced TNM 
stages,  high alpha-fetoprotein (AFP) levels and high 
des-gamma-carboxy prothrombin (DCP) levels were 
signiﬁcantly observed in the humped HCC groups.
　 Table 2 shows the number of humped and non-
humped HCCs.  HCC was deﬁned as belonging to the 
segment where the tumor was mainly located.  The 
frequency of humped HCC was calculated for each 
lobe and each segment.  The right lobe had twice as 
many HCCs as the left lobe,  and humped HCCs were 
more frequently observed in the right lobe (27.4ｵ of 
all HCCs in the right lobe) than in the left (10.1ｵ; p
＝0.003,  the x2 test).  Furthermore,  humped HCCs 
were most often located in Segment 7 (20.2ｵ).  
Similar results were observed in the severely humped 
HCC group.  As shown in Fig.  2,  mean tumor size 
was 2,942mm2 (range,  125-21,150mm2).  Twelve 
humped HCCs were large in size (＞4cm in diameter),  
while 18 were small tumors ｦ2cm in diameter.  
Severely humped HCCs were not always large tumors.  
Tumor size was not signiﬁcantly associated with tumor 
location (p＝0.097,  the Kruskal-Wallis test).
　 Fig.  3 shows the association of tumor protrusion 
with TNM stage and Child-Pugh stage.  Most patients 
with humped HCC were at TNM stage 3 (54.9ｵ) or 
stage 4 (41.2ｵ),  (p＜0.001,  the Kruskal-Wallis test).  
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Fig. 1　 Measurement of humped HCC.  Image analysis was undertaken by measuring the HCC area using a TFS-7000 DICOM Viewer 
(Toshiba Medical Systems Corporation,  Tokyo,  Japan).  Humped and non-humped areas of the tumor were traced on the screen.  The 
program calculated the traced area automatically.  This ﬁgure shows an example of an actual analysis.  Area A is 1,429mm2,  while area B 
is 770mm2.  The humped area (area B) is greater than one-third of the HCC (total of areas A and B).
Conversely,  no signiﬁcant correlations were noted 
between tumor protrusion and Child-Pugh stage (p＝
0.12).  Interestingly,  among the patients in Child-Pugh 
stage A,  9 of the 15 HBV-infected patients had 
humped HCC (60ｵ) compared to 15 of 82 HCV-
infected patients (18.3ｵ,  p＜0.001,  the x2 test).
　 Next,  we studied the relationships between humped 
HCC and HCC treatment.  When patients received 
several treatments such as TACE,  percutaneous abla-
tion and resection within a 1-month interval,  succes-
sive treatments were counted as 1 session of treat-
ment.  There was no statistical diﬀerence in the 
frequency of humped HCC among the treatment 
groups (Table 1; p＝0.19,  the Kruskal-Wallis test).  
However,  as shown in Fig.  4,  large humped tumors 
(＞4cm in diameter) were more frequently observed 
among treatment-naïve patients (38.5ｵ) compared with 
patients with recurrent HCC (5.9ｵ; p＝0.012,  the 
Fisher exact probability test).  In patients with recur-
rent HCC who did not have humped HCC initially,  
patients with multiple treatments of ｧ4 sessions had 
more humped HCC (33.8ｵ) than those with 1-3 ses-
sions of treatments (16.7ｵ; p＝0.042,  the x2 test).  
Interestingly,  the humped HCC group had a signiﬁ-
cantly longer duration after initial HCC diagnosis 
(58.6±37.2 months) than the non-humped HCC group 
(38.2±28.0 months; p＝0.0014,  the Student t-test).  
Tumor invasion in the portal vein was frequently rec-
ognized among humped tumors in the right lobe 
(38.1ｵ) rather than in the left (22.2ｵ),  although this 
diﬀerence was not statistically signiﬁcant (p＝0.31,  
the Fisher exact probability test).
　 HCC sometimes acquires blood supply through 
ExHV.  It is unclear whether HCCs fed through 
ExHV are more often humped.  Thirty-three HCCs,  
including humped or non-humped tumors,  were sup-
plied through ExHV in this study.  ExHV included the 
right inferior phrenic artery (n＝20),  cystic artery (n
＝8),  right adrenal artery (n＝2),  gastro-duodenal 
artery (n＝1),  left gastric artery (n＝1),  and left 
inferior phrenic artery (n＝1).  The frequency of 
humped HCCs supplied through ExHV was 27.3ｵ,  
which was similar to that through hepatic arteries 
(28.8ｵ).  Tumor size of the humped HCCs did not 
diﬀer statistically between the groups (p＝0.82,  the 
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Table 2　 Humped HCC was more frequently observed in the right lobe
All HCCs Humped (%) S-Humped (%)
Left lobe  89  9 (10.1) 4 (4.5)
Segment 1  56  2 ( 3.6) 1 (1.8)
2  58  1 ( 1.7) 1 (1.7)
3  62  2 ( 3.2) 1 (1.6)
4  73  4 ( 5.5) 1 (1.4)
Right lobe 157 46 (29.3) 14 (8.9)
Segment 5  88  4 ( 4.5) 0 (0)
6  97  9 ( 9.3) 5 (5.2)
7  99 20 (20.2) 8 (8.1)
8 103 13 (12.6) 1 (1.0)
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Fig. 2　 Humped HCC is frequently observed in the right lobe.  A 
total of 51 DSA images showed humped HCC.  This ﬁgure shows 
the distribution and size of humped HCCs.  The vertical axis shows 
tumor size,  and the horizontal axis shows Couinaud segments.  The 
mean tumor size was 2,042mm2 (range,  125-21,150mm2).  Open 
circles are humped HCC,  and closed circles are severely humped 
HCC.  The circles with arrows indicated ruptured HCC.  No signiﬁ-
cant associations were noted with humped HCC in terms of distri-
bution and tumor size (p＝0.097,  the Kruskal-Wallis test).
x2 test).  HCCs fed through ExHV were often observed 
in patients who underwent multiple treatments of ｧ4 
sessions; however,  they were not identiﬁed in any 
treatment-naive patients,  revealing that blood-supply 
through ExHV is associated with the time of HCC 
treatment,  but not with tumor protrusion.
　 In order to determine factors that strongly aﬀect 
tumor protrusion,  we assessed individual factors of 
TNM classiﬁcation (tumor number,  tumor size,  tumor 
invasion in the portal vein,  lymph node metastasis,  
and distant metastasis) in univariate regression analy-
sis (Table 3).  All 3 factors for tumor staging exhib-
ited strong associations with tumor protrusion.  
Distant metastasis showed high correlations with 
tumor protrusion,  although the number of patients 
with distant metastasis was small (n＝7).  Multivariate 
regression analysis indicated that tumor invasion in the 
portal vein and tumor number,  rather than tumor size,  
were important factors for tumor protrusion.  Tumor 
invasion in the portal vein was seen in 35.3ｵ of 
patients with humped tumors,  compared to 14.1ｵ of 
patients with non-humped ones (p＝0.0028,  the x2 
test).
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Fig. 3　 Tumor protrusion is associated with TNM stage, but not Child-Pugh stage. The upper half of the ﬁgure shows the frequency of 
humped and non-humped HCC at each stage based on tumor progression (TNM stage). Humped HCC was signiﬁcantly more common at 
stage 3 (30.8%) or 4 (51.2%) than at stage 1 or 2 (p＜0.001, the Kruskal-Wallis test). The lower half of the ﬁgure shows the frequency of 
humped and non-humped HCC at each stage of liver damage (Child-Pugh stage). No signiﬁcant association was noted between tumor 
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Fig. 4　 Tumor protrusion is associated with the time of treatment.  
The ﬁgure shows the association between tumor size and the time 
of HCC treatment.  Large-sized humped tumors (＞4cm in diame-
ter) were more frequently observed among treatment-naïve patients 
(38.5%),  compared with patients with recurrent HCC (5.9%; p＝
0.012,  the Fisher exact probability test).
Discussion
　 Recent progress in HCC treatment has contributed 
to improvement of patient survival [1,  2].  However,  
HCC recurrence occasionally occurs with humped or 
ruptured HCC.  No prospective randomized control 
trials or comparative studies have examined tumor 
protrusion.  Only a few reports [14,  15] studied the 
resected tissues of humped or ruptured HCC and 
discussed successful treatments.  This is a retrospec-
tive study with consecutive HCC cases,  focusing on 
the characteristics of humped HCC with clinical and 
radiological analysis.  We compared clinical and radio-
logical factors between humped HCC and severely 
humped HCC,  and suggested they might be similar in 
their essential characters.  Our results revealed that 
humped HCC is often observed in patients at advanced 
TNM stages with multiple treatments.  Furthermore,  
tumor invasion in the portal vein,  rather than tumor 
size,  might play important roles in the mechanisms of 
tumor protrusion.
　 The frequency of humped HCC was previously 
reported at 7.8ｵ,  which is close to that of severely 
humped HCC (10.1ｵ) in our results [14].  Distribu-
tion of bleeding or the humped site remains controver-
sial [6,  7,  14-17].  Chen et al.  reported more rup-
tured tumors in the left [7],  while no diﬀerence in the 
distribution was reported by Kanematsu et al.  [6].  A 
recent study by Battula et al.  showed more ruptured 
tumors in the right [17],  similar to our results of 
humped HCC.  As for the distribution of humped 
tumors,  we doubted the associations of ExHAs,  
because ExHAs supplies blood for tumors from out-
side the liver.  Therefore,  we evaluated ExHAs with 
regard to tumor protrusion,  and revealed that ExHAs 
are not signiﬁcantly associated with tumor protrusion.  
When comparing humped HCC in the right lobe and 
those in the left,  no signiﬁcant diﬀerence was identi-
ﬁed in the patient background or tumor size,  or the 
frequency of tumor invasion in the portal vein.  
Tumors might be diﬃcult to expand out of liver sur-
face if they face to diaphragm,  both in the right lobe 
and in the left.
　 Our analysis for the mechanisms of tumor protru-
sion showed that tumor invasion in the portal vein,  
independently from tumor size,  might be signiﬁcantly 
associated with tumor protrusion.  Ong et al.  reported 
that when portal veins are peripherally obstructed,  
tumors cannot be drained by the portal veins,  causing 
high pressure in the tumors [18].  High pressure in 
the tumor might result in tumor protrusion if the 
tumor is located on the liver surface.  Nakashima et al.  
precisely studied portal vein invasion of HCC with 
resected HCC tissues and revealed that 33.4ｵ of 
tumors as small as 2cm in diameters obstructed the 
portal vein [14].  Obstructions of the peripheral por-
tal veins might occur on some occasions associated 
with treatments.  When the tumors were treated with 
ablation,  the peripheral portal veins adjacent to the 
tumors might be injured.  Segmental TACE might 
cause an overﬂow of iodized oil to segmental portal 
veins [19-21].  Atrophic changes of the liver paren-
chyma surrounding the HCC might be associated with 
tumor protrusion.  Patients who receive multiple 
treatments might consequently be at more risk of 
peripheral portal obstructions,  as shown in the 
results.  The incidence of protrusion might be pre-
sumed to be mainly associated with the location of the 
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Table 3　 Univariate and multivariate regression analysis for humped HCC
Univariate analysis Multivariate analysis
Factors Odds ratio (Range†) p Odds ratio (Range†) p
TNM stage‡ 0.32 (0.19-0.53) ＜0.001
Tumor 2.87 (1.76-4.69) ＜0.001
Node 1.17 (0.10-13.1) 0.90
Metastasis 9.19 (1.84-45.8) 0.007
Tumor number (not single) 3.00 (1.91-22.3) 0.003 3.70 (1.02-13.4) 0.047
Tumor size (ｧ2cm) 5.78 (1.69-19.8) 0.005 3.03 (0.83-11.1) 0.095
VP 3.49 (1.66-7.33) 0.001 2.47 (1.15-5.31) 0.020
Tumor,  Tumor stage in TNM classiﬁcation; Node,  Lymph node metastasis; Metastasis,  Distant metastasis; VP,  Tumor invasion in the 
portal vein; †: 95% conﬁdence interval; ‡: Tumor-node-metastasis stage according to the Liver Cancer Study Group of Japan.
tumor and with tumor size.  The present study ana-
lyzed the location of the tumor,  and tumor size as for 
tumor protrusion,  and revealed that large size tumors 
in poor control cause portal thrombus in some cases,  
while humped HCCs sometimes occur in small sized 
tumors,  even when HCC control is good.  We also 
revealed that portal vein thrombus is an independent 
factor for protrusion in multivariate analysis,  sug-
gesting that portal vein thrombus is not just a con-
comitant phenomenon,  but one of major factors for 
tumor protrusion.  
　 In conclusion,  humped HCC is often observed in 
patients at advanced TNM stages regardless of Child-
Pugh stage.  HCC recurrence with humped HCC might 
occur more frequently after multiple treatments.  
Tumor factors of TNM classiﬁcation,  especially 
tumor invasion in the portal vein,  might be associated 
with tumor protrusion.
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